Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Leucovorin, and Fluorouracil in Pancreatic and Biliary Cancer
NCT00010088Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Jan 1999
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine, folinic acid and fluorouracil in pancreatic cancer (PC) and biliary tract cancer (BTC), sponsored by GERCOR. Primary endpoint: Objective Response Rate. Status: unknown.
02
Drugs
gemcitabinefolinic acidfluorouracil
03
Conditions
pancreatic cancer (PC)biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00010088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010088.